Integra LifeSciences Holdings Corporation (IART): Price and Financial Metrics
GET POWR RATINGS... FREE!
IART Price/Volume Stats
Current price | $38.45 | 52-week high | $62.99 |
Prev. close | $38.48 | 52-week low | $37.90 |
Day low | $37.90 | Volume | 971,200 |
Day high | $39.11 | Avg. volume | 579,110 |
50-day MA | $53.24 | Dividend yield | N/A |
200-day MA | $52.53 | Market Cap | 3.15B |
IART Stock Price Chart Interactive Chart >
IART POWR Grades
- Value is the dimension where IART ranks best; there it ranks ahead of 85.27% of US stocks.
- The strongest trend for IART is in Growth, which has been heading down over the past 179 days.
- IART ranks lowest in Sentiment; there it ranks in the 13th percentile.
IART Stock Summary
- IART's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 237.05 -- higher than 89.17% of US-listed equities with positive expected earnings growth.
- INTEGRA LIFESCIENCES HOLDINGS CORP's stock had its IPO on August 16, 1995, making it an older stock than 75.26% of US equities in our set.
- INTEGRA LIFESCIENCES HOLDINGS CORP's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 8.12%, greater than the shareholder yield of 79.42% of stocks in our set.
- If you're looking for stocks that are quantitatively similar to INTEGRA LIFESCIENCES HOLDINGS CORP, a group of peers worth examining would be SSD, HUN, CW, PLPC, and BRC.
- IART's SEC filings can be seen here. And to visit INTEGRA LIFESCIENCES HOLDINGS CORP's official web site, go to www.integralife.com.
IART Valuation Summary
- In comparison to the median Healthcare stock, IART's price/earnings ratio is 19.92% lower, now standing at 19.3.
- Over the past 243 months, IART's price/sales ratio has gone down 3.8.
Below are key valuation metrics over time for IART.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
IART | 2023-05-23 | 2.1 | 2.0 | 19.3 | 18.2 |
IART | 2023-05-22 | 2.7 | 2.5 | 24.2 | 21.5 |
IART | 2023-05-19 | 2.6 | 2.4 | 23.7 | 21.2 |
IART | 2023-05-18 | 2.6 | 2.4 | 23.7 | 21.1 |
IART | 2023-05-17 | 2.6 | 2.4 | 23.7 | 21.1 |
IART | 2023-05-16 | 2.6 | 2.4 | 23.3 | 20.9 |
IART Growth Metrics
- Its 2 year price growth rate is now at 21.32%.
- The 5 year price growth rate now stands at 11.72%.
- Its year over year revenue growth rate is now at 13.17%.

The table below shows IART's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 1,565.168 | 248.412 | 172.988 |
2022-06-30 | 1,566.838 | 262.878 | 166.302 |
2022-03-31 | 1,559.015 | 287.69 | 156.582 |
2021-12-31 | 1,542.448 | 312.427 | 169.075 |
2021-09-30 | 1,525.571 | 323.412 | 216.435 |
2021-06-30 | 1,508.942 | 310.272 | 205.543 |
IART's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- IART has a Quality Grade of C, ranking ahead of 70.12% of graded US stocks.
- IART's asset turnover comes in at 0.411 -- ranking 114th of 186 Medical Equipment stocks.
- XENT, ALGN, and CODX are the stocks whose asset turnover ratios are most correlated with IART.
The table below shows IART's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.411 | 0.614 | 0.104 |
2021-06-30 | 0.416 | 0.616 | 0.103 |
2021-03-31 | 0.388 | 0.613 | 0.086 |
2020-12-31 | 0.395 | 0.620 | 0.065 |
2020-09-30 | 0.406 | 0.620 | 0.060 |
2020-06-30 | 0.411 | 0.617 | 0.030 |
IART Price Target
For more insight on analysts targets of IART, see our IART price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $77.70 | Average Broker Recommendation | 1.75 (Moderate Buy) |
Integra LifeSciences Holdings Corporation (IART) Company Bio
Integra LifeSciences develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates in five segments: U.S. Neuro-surgery; U.S. Extremities; U.S. Instruments; U.S. Spine and Other; and International. The company was founded in 1989 and is based in Plainsboro, New Jersey.
Latest IART News From Around the Web
Below are the latest news stories about INTEGRA LIFESCIENCES HOLDINGS CORP that investors may wish to consider to help them evaluate IART as an investment opportunity.
Wall Street Stalls As Default Deadline LoomsWall Street is lower this afternoon as the default debate rages on. |
Integra (IART) Builds Advanced R&D Facility in New JerseyIntegra (IART) opens the Dr. Richard E. Caruso Center of Innovation and Learning in New Jersey. |
Investors in Integra LifeSciences Holdings (NASDAQ:IART) have unfortunately lost 24% over the last five yearsThe main aim of stock picking is to find the market-beating stocks. But the main game is to find enough winners to more... |
Integra LifeSciences Opens New Center of Innovation and LearningNew facility is dedicated to Dr. Richard E. Caruso, late company founder Dr. Richard E. Caruso Center of Learning and Innovation Integra president and CEO Jan De Witte, Integra chairman Stuart Essig, and Mayor Peter Cantu, with Integra board members and leader cutting the ribbon of the Dr. Richard E. Caruso Center of Innovation and Learning. PRINCETON, N.J., May 11, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, host |
Integra LifeSciences To Host Investor Day On May 4, 2023PRINCETON, N.J., May 03, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will host an Investor Day meeting from 8:30 a.m. to approximately 12:00 p.m., U.S. eastern time on May 4, 2023 in New York, NY. The event will be hosted by Jan DeWitte, president and chief executive officer, along with members of Integra’s executive leadership team. A live webcast will be available on the Investors section of the Company’s websi |
IART Price Returns
1-mo | -30.50% |
3-mo | -32.73% |
6-mo | -28.39% |
1-year | -38.13% |
3-year | -26.28% |
5-year | -39.71% |
YTD | -31.43% |
2022 | -16.30% |
2021 | 3.19% |
2020 | 11.39% |
2019 | 29.22% |
2018 | -5.77% |
Continue Researching IART
Want to do more research on Integra Lifesciences Holdings Corp's stock and its price? Try the links below:Integra Lifesciences Holdings Corp (IART) Stock Price | Nasdaq
Integra Lifesciences Holdings Corp (IART) Stock Quote, History and News - Yahoo Finance
Integra Lifesciences Holdings Corp (IART) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...